首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation
【24h】

Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation

机译:预测慢性肾病的沉康作用机制:网络药理学研究与实验验证

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: Traditional Chinese medicine provides a unique curative treatment of complex chronic diseases, including chronic kidney disease (CKD), which is not effectively treated with the current therapies. The pharmacological mechanisms of Shenkang (SK), a herbal medicine containing rhubarb (Rheum palmatum L. or R. tanguticum Maxim. ex Balf.), red sage (Salvia miltiorrhiza Bunge), safflower (Carthamus tinctorius L.), and astragalus (Astragalus mongholicus Bunge), widely used to treat CKD in China, are still unclear.
机译:民族科医药相关性:中药提供了复杂的慢性病的独特疗法治疗,包括慢性肾病(CKD),其没有用当前疗法有效处理。 沉康(SK)的药理机制,含有大黄的草药(Rheum Palmatum L.或R. Tanguticum Maxim。),红鼠尾草(Salvia Miltiorrhiza Bunge),红花(Carthamus Tinctorius L.)和黄芪(黄芪 广泛用于在中国治疗CKD的Mongholicus Bunge仍然不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号